US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalA
AQST
Aquestive Therapeutics
4.18
-0.05-1.18%After Hours: 4.160 -0.02 -0.48%19:28 09/06 EDT
OPEN/PREV CLOSE4.230/4.230
TODAY RANGE4.100-4.270
VOL625.67K
MARKET CAP380.63M
52 WEEK RANGE1.251-6.23
AVG VOL (3M)1.50M
% TURNOVER0.69%
TURNOVER--
P/E (TTM)-11.7218
% RANGE4.02%
EPS(TTM)-0.3566
P/E(FORWARD)-7.7122
P/B-10.7290
BVPS-0.3896
DIVIDEND--
P/S5.66
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP359.93M
SHARES OUTSTANDING91.06M
NEXT EARNINGS11/04-11/08
FREE FLOAT86.11M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·08/23 03:37
Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings
Seeking Alpha·08/20 08:12
Aquestive Therapeutics: Robust Development Of Oral Emergency Therapies Will Likely Pay Off Into 2025
Seeking Alpha·08/13 16:26
Raymond James ups ARS to strong buy, cites FDA neffy approval
Dow Jones·08/12 14:16
Aquestive Therapeutics Price Target Maintained With a $9.00/Share by JMP Securities
TipRanks·08/12 13:36
Aquestive Therapeutics (AQST) Gets a Buy from Lake Street
Seeking Alpha·08/09 19:00
Oppenheimer sees Aquestive benefitting from FDA okay of rival drug
TipRanks·08/08 13:25
Oppenheimer Keeps Their Buy Rating on Aquestive Therapeutics (AQST)
Same Industry
Name/Symbol
Change%
Price